PD-L1 upregulation may become an effective way to suppress any potential benefit from Treg cells in DLBCL, and help explaining the relative decrease in Treg numbers observed in murine PD-L1+ DLBCL [133]. The gene discussed is CD274; the disease is diffuse large B-cell lymphoma.